NEULAND LABORATORIES Q2 FY25 Results
NEULAND LABORATORIES has released its financial results for the Q2 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 310.84 Cr
- Quarter-on-Quarter (QoQ) Change: -29.29% (Previous Quarter: Rs. 439.60 Cr )
- Year-on-Year (YoY) Change: -25.59% (Same Quarter Last Year: Rs. 417.75 Cr )
Profitability Metrics
- Net Profit: Rs. 32.84 Cr
- QoQ Profit Change: -66.44% (Previous Quarter: Rs. 97.87 Cr )
- YoY Profit Change: -63.20% (Same Quarter Last Year: Rs. 89.25 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 25.60
- QoQ EPS Change: -66.44% (Previous Quarter: Rs. 76.28)
- YoY EPS Change: -63.20% (Same Quarter Last Year: Rs. 69.56)
Performance Summary
Challenging
NEULAND LABORATORIES faced significant challenges with both sales and profits declining sharply. This might reflect tough market conditions or internal changes.
This analysis provides a snapshot of NEULAND LABORATORIES's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.